Terns Pharmaceuticals Ownership | Who Owns Terns Pharmaceuticals?

Terns Pharmaceuticals Ownership Summary

Terns Pharmaceuticals is owned by 51.25% institutional investors, 0.25% insiders, and 48.50% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.27% of TERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.85% of its assets in Terns Pharmaceuticals shares.

TERN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Terns Pharmaceuticals	51.25%	0.25%	48.50%
Sector	Healthcare Stocks	35.52%	11.86%	52.62%
Industry	Biotech Stocks	35.67%	11.81%	52.52%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	9.57M	10.27%	$504.51M
Morgan stanley	6.45M	6.92%	$340.00M
Avoro capital advisors	5.70M	6.11%	$300.24M
Vanguard group	5.52M	6.02%	$223.17M
Blackrock	4.12M	5.53%	$28.06M
Holocene advisors, lp	4.12M	4.42%	$216.99M
Citadel advisors	3.22M	3.45%	$169.70M
Nuveen asset management	2.63M	3.38%	$14.59M
Millennium management	3.01M	3.23%	$158.77M
Hbk investments l p	2.95M	3.17%	$155.52M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Acorn capital advisors	1.75M	26.17%	$92.06M
Beryl capital management	478.75K	23.00%	$25.24M
Acuta capital partners	495.77K	18.44%	$26.14M
Monashee investment management	300.00K	8.60%	$15.82M
Harvest management	257.50K	6.58%	$13.58M
Slotnik capital	420.70K	6.49%	$22.18M
Ikarian capital	1.46M	6.23%	$76.78M
Vivo capital	1.33M	5.87%	$70.35M
Catalio capital management, lp	409.03K	4.50%	$21.56M
Chicago capital management	129.22K	4.26%	$5.14M

Top Buyers

Holder	Shares	% Assets	Change
Hbk investments l p	2.95M	1.58%	2.95M
Glazer capital	2.30M	2.57%	2.30M
Millennium management	3.01M	0.07%	2.02M
Balyasny asset management	2.78M	0.19%	1.89M
Paradigm biocapital advisors lp	2.22M	2.39%	1.41M

Top Sellers

Holder	Shares	% Assets	Change
Vivo capital	1.33M	5.87%	-4.01M
Vestal point capital, lp	1.00M	1.47%	-3.50M
Adage capital partners gp	2.12M	0.17%	-3.43M
Orbimed advisors	-	-	-2.15M
Avidity partners management lp	-	-	-2.13M

New Positions

Holder	Shares	% Assets	Change	Value
Hbk investments l p	2.95M	1.58%	2.95M	$155.52M
Glazer capital	2.30M	2.57%	2.30M	$121.02M
Whitebox advisors	1.00M	0.65%	1.00M	$52.72M
Nexpoint asset management	904.20K	3.20%	904.20K	$47.67M
First trust capital management	904.16K	2.50%	904.16K	$47.67M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-9.00
True wealth design	-11.00
Capital performance advisors llp	-23.00
Versant capital management	-36.00
Bellevue asset management	-43.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	192	-24.41%	47,746,628	-61.05%	51	0.29%	149	-23.59%	24	-42.86%
Dec 31, 2025	148	-	58,439,899	-34.07%	63	0.68%	114	56.16%	25	-40.48%
Sep 30, 2025	139	6.92%	87,383,371	5.14%	95	1.16%	67	-6.94%	40	33.33%
Jun 30, 2025	129	-7.19%	83,090,778	-0.02%	90	1.10%	71	1.43%	30	-23.08%
Mar 31, 2025	139	-13.66%	83,111,324	-3.50%	90	0.74%	70	-33.33%	39	21.88%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	3.29M	2.85%	86.47K
Vanguard US Total Market Shares ETF	2.09M	2.39%	792.70K
iShares Russell 2000 ETF	2.23M	1.93%	-
Lord Abbett Growth Leaders I	1.59M	1.38%	-
Lord Abbett & Co. Growth Equity- SA	1.59M	1.38%	601.50K
American Funds SMALLCAP World A	1.42M	1.23%	364.50K
CREF Stock R1	1.08M	1.23%	-160.00K
US Small-Cap Growth II Equity Comp	1.04M	1.23%	529.45K
T. Rowe Price New Horizons	1.04M	1.23%	-
HBM Healthcare Investments AG Ord	1.15M	1.06%	478.02K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 01, 2026	Kuriakose Emil	Chief Medical Officer	Sell	$49.69K
Mar 16, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$550.08K
Mar 16, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$131.03K
Feb 17, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$319.96K
Feb 17, 2026	Burroughs Amy L.	Chief Executive Officer	Sell	$162.50K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	1
2026 Q1	-	10
2025 Q4	-	2
2025 Q3	-	1
2025 Q2	6	1

TERN Ownership FAQ

Who Owns Terns Pharmaceuticals?

Terns Pharmaceuticals shareholders are primarily institutional investors at 51.25%, followed by 0.25% insiders and 48.50% retail investors. The average institutional ownership in Terns Pharmaceuticals's industry, Biotech Stocks , is 35.67%, which Terns Pharmaceuticals exceeds.

Who owns the most shares of Terns Pharmaceuticals?

Terns Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (9.57M shares, 10.27%), Morgan stanley (6.45M shares, 6.92%), and Avoro capital advisors (5.7M shares, 6.11%). Together, they hold 23.31% of Terns Pharmaceuticals’s total shares outstanding.

Does Blackrock own Terns Pharmaceuticals?

Yes, BlackRock owns 5.53% of Terns Pharmaceuticals, totaling 4.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 28.06M$. In the last quarter, BlackRock increased its holdings by 804.98K shares, a 24.28% change.

Who is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Acorn capital advisors is Terns Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 26.17% of its assets in 1.75M Terns Pharmaceuticals shares, valued at 92.06M$.

Who is the top mutual fund holder of Terns Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Terns Pharmaceuticals shares, with 2.85% of its total shares outstanding invested in 3.29M Terns Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools